Recombinant multi-species CRH/CRF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CRH/CRF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the corticotropin-releasing factor family. The encoded preproprotein is proteolytically processed to generate the mature neuropeptide hormone. In response to stress, this hormone is secreted by the paraventricular nucleus (PVN) of the hypothalamus, binds to corticotropin releasing hormone receptors and stimulates the release of adrenocorticotropic hormone from the pituitary gland. Marked reduction in this protein has been observed in association with Alzheimer's disease. Autosomal recessive hypothalamic corticotropin deficiency has multiple and potentially fatal metabolic consequences including hypoglycemia and hepatitis. In addition to production in the hypothalamus, this protein is also synthesized in peripheral tissues, such as T lymphocytes, and is highly expressed in the placenta. In the placenta it is a marker that determines the length of gestation and the timing of parturition and delivery. A rapid increase in circulating levels of the hormone occurs at the onset of parturition, suggesting that, in addition to its metabolic functions, this protein may act as a trigger for parturition. [provided by RefSeq, Nov 2015]
The Alternative Names of target: CRF,CRH,CRH1,Corticoliberin,Corticotropin-releasing factor (CRF),Corticotropin-releasing hormone,Crh,Gm1347
Go
to CRH/CRF products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T64137-Ag-1/ GM-Tg-hg-T64137-Ag-2 | Human CRH/CRF protein | Human |
| GM-Tg-rg-T64137-Ag-1/ GM-Tg-rg-T64137-Ag-2 | Rat CRH/CRF protein | Rat |
| GM-Tg-mg-T64137-Ag-1/ GM-Tg-mg-T64137-Ag-2 | Mouse CRH/CRF protein | Mouse |
| GM-Tg-cynog-T64137-Ag-1/ GM-Tg-cynog-T64137-Ag-2 | Cynomolgus/Rhesus macaque CRH/CRF protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T64137-Ag-1/ GM-Tg-felg-T64137-Ag-2 | Feline CRH/CRF protein | Feline |
| GM-Tg-cang-T64137-Ag-1/ GM-Tg-cang-T64137-Ag-2 | Canine CRH/CRF protein | Canine |
| GM-Tg-bovg-T64137-Ag-1/ GM-Tg-bovg-T64137-Ag-2 | Bovine CRH/CRF protein | Bovine |
| GM-Tg-equg-T64137-Ag-1/ GM-Tg-equg-T64137-Ag-2 | Equine CRH/CRF protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T64137-Ag-1/ GM-Tg-hg-T64137-Ag-2;
GM-Tg-rg-T64137-Ag-1/ GM-Tg-rg-T64137-Ag-2;
GM-Tg-mg-T64137-Ag-1/ GM-Tg-mg-T64137-Ag-2; GM-Tg-cynog-T64137-Ag-1/ GM-Tg-cynog-T64137-Ag-2; GM-Tg-felg-T64137-Ag-1/ GM-Tg-felg-T64137-Ag-2; GM-Tg-cang-T64137-Ag-1/ GM-Tg-cang-T64137-Ag-2; GM-Tg-bovg-T64137-Ag-1/ GM-Tg-bovg-T64137-Ag-2; GM-Tg-equg-T64137-Ag-1/ GM-Tg-equg-T64137-Ag-2 |
| Products Name | CRH/CRF protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CRH/CRF |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CRH/CRF protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.